Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma

Julien Caldéraro, Luca Di Tommaso, Pascale Maillé, Aurélie Bèaufrere, Công Trung Nguyễn, Lara R. Heij, Viviane Gnemmi, Rondell P. Graham, Frédéric Charlotte, Suzanne Chartier, Dominique Wendum, Mukul Vij, Daniela Allende, Alba Díaz, Carla Fuster, Benjamin Rivière, Astrid Herrero, Jérémy Augustin, Katja Evert, Diego F. Calvisi, Wei Qiang Leow, Howard H.w. Leung, Jan Bednarsch, Emmanuel Boleslawski, Mohamed Rela, Anthony W.h. Chan, Alejandro Forner, María Reig, Anaïs Pujals, Loëtitia Favre, Manon Allaire, Olivier Scatton, Arnaud Uguen, Eric Trépo, Lukas Otero Sanchez, Denis Chatelain, Myriam Remmelink, Camille Boulagnon‐Rombi, Céline Bazille, Nathalie Stürm, Benjamin Menahem, É. Frouin, David Tougeron, Christophe Tournigand, Emmanuelle Kempf, Haeryoung Kim, Massih Ningarhari, Sophie Michalak-Provost, Jakob Nikolas Kather, Annette S.h. Gouw, Purva Gopal, Raffaele Brustia, Éric Vibert, Kornelius Schulze, Darius F. Rüther, Sören Weidemann, Rami Rhaiem, Jean‐Charles Nault, Alexis Laurent, Giuliana Amaddeo, Hélène Regnault, Eléonora De Martin, Christine Sempoux, Pooja Navale, Jayendra Shinde, Ketan Bacchuwar, Maria Westerhoff, Regina Cheuk‐Lam Lo, Mylène Sebbagh, Catherine Guettier, Marie Lequoy, Mina Komuta, Marianne Ziol, Valérie Paradis, Jeanne Shen, Stefano CarusoJournal of Hepatology 2022 · DOI

Abstract

There are different types of primary liver cancers (i.e. cancers that originate in the liver). Accurately identifying a specific subtype of primary liver cancer (and determining its associated prognosis) is important as it can have a major impact on treatment allocation. Herein, we show that a protein called Nestin could be used to refine risk stratification and improve treatment allocation for patients with combined hepatocellular carcinoma, a rare but highly aggressive subtype of primary liver cancer.
BibTeX
@article{calderaro2022nestin,
  author = {Julien Caldéraro and Luca Di Tommaso and Pascale Maillé and Aurélie Bèaufrere and Công Trung Nguyễn and Lara R. Heij and Viviane Gnemmi and Rondell P. Graham and Frédéric Charlotte and Suzanne Chartier and Dominique Wendum and Mukul Vij and Daniela Allende and Alba Díaz and Carla Fuster and Benjamin Rivière and Astrid Herrero and Jérémy Augustin and Katja Evert and Diego F. Calvisi and Wei Qiang Leow and Howard H.W. Leung and Jan Bednarsch and Emmanuel Boleslawski and Mohamed Rela and Anthony W.H. Chan and Alejandro Forner and María Reig and Anaïs Pujals and Loëtitia Favre and Manon Allaire and Olivier Scatton and Arnaud Uguen and Eric Trépo and Lukas Otero Sanchez and Denis Chatelain and Myriam Remmelink and Camille Boulagnon‐Rombi and Céline Bazille and Nathalie Stürm and Benjamin Menahem and É. Frouin and David Tougeron and Christophe Tournigand and Emmanuelle Kempf and Haeryoung Kim and Massih Ningarhari and Sophie Michalak-Provost and Jakob Nikolas Kather and Annette S.H. Gouw and Purva Gopal and Raffaele Brustia and Éric Vibert and Kornelius Schulze and Darius F. Rüther and Sören Weidemann and Rami Rhaiem and Jean‐Charles Nault and Alexis Laurent and Giuliana Amaddeo and Hélène Regnault and Eléonora De Martin and Christine Sempoux and Pooja Navale and Jayendra Shinde and Ketan Bacchuwar and Maria Westerhoff and Regina Cheuk‐Lam Lo and Mylène Sebbagh and Catherine Guettier and Marie Lequoy and Mina Komuta and Marianne Ziol and Valérie Paradis and Jeanne Shen and Stefano Caruso},
  title = {{Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma}},
  journal = {Journal of Hepatology},
  year = {2022},
  doi = {10.1016/j.jhep.2022.07.019},
}

Loading related content...

Figure